<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00780429</url>
  </required_header>
  <id_info>
    <org_study_id>06/2006/REVO</org_study_id>
    <nct_id>NCT00780429</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients</brief_title>
  <official_title>Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in
      renal transplant patients already on long-term MMF treatment (at least 6 months
      post-transplant; at least 3 months in therapy).

      Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological
      activity and if there are any correlations with the risk of AR.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">54</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>MMF+cyclosporine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>MMF+tacrolimus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>MMF+sirolimus</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female renal transplant patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Renal transplant recipients

          -  Age range: 18-70

          -  Patients taking MMF

          -  Able to understand and sign an informed consent

        Exclusion Criteria:

          -  Active myelodepression

          -  Systemic infections or other that may affect MMF absorption

          -  Pregnancy/breastfeeding

          -  (History of) cancer

          -  Drug abuse, psychiatric conditions

          -  Already enrolled in other clinical trials or participation ended less than one month
             earlier

          -  Known sensitivity to polysorbate 80 or MMF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Fondazione Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2008</study_first_submitted>
  <study_first_submitted_qc>October 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2008</study_first_posted>
  <last_update_submitted>October 24, 2008</last_update_submitted>
  <last_update_submitted_qc>October 24, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Antonio Dal Canton</name_title>
    <organization>IRCCS Fondazione Policlinico San Matteo</organization>
  </responsible_party>
  <keyword>kidney</keyword>
  <keyword>transplant</keyword>
  <keyword>Mycophenolic acid</keyword>
  <keyword>Inosine monophosphate dehydrogenase</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

